查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1498733

精准医疗市场中的人工智慧，按技术、按组件、按治疗应用和按地区 - 2024-2032 年行业分析、市场规模、市场份额和预测

Artificial Intelligence in Precision Medicine Market, By Technology, By Component, By Therapeutic Application, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2024-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 322 Pages | 商品交期: 2-3个工作天内

价格

报告要点

2023年，精准医疗中的人工智慧市场规模为18.542亿美元，2024年至2032年复合年增长率为20.10%。

精准医疗市场中的人工智慧-市场动态

慢性病盛行率不断上升推动市场成长

慢性病，也称为非传染性疾病 (NCD)，是一大类医疗疾病，包括呼吸系统疾病、糖尿病、癌症和心血管疾病。它们的持续时间较长、进展缓慢以及对医疗护理和监督的持续需求决定了它们。世界卫生组织 (WHO) 报告称，全球近 71% 的死亡归因于慢性病，其中低收入和中等收入国家占这些死亡人数的 85%，令人震惊。慢性病对人们的生活品质、医疗保健系统、劳动生产力以及个人和家庭的生活品质有重大的负面社会经济影响。人工智慧使医疗保健产业发生了重大转变，特别是在机器学习和深度学习领域。人工智慧能够产生预测模型、处理和分析大量资料集以及识别复杂的模式。随着人工智慧在精准医学中的应用，透过探索遗传组成、疾病易感性和治疗结果之间的复杂相互作用，可以实现更精确的诊断和个人化的治疗介入。基因组研究是人工智慧在精准医学中的主要用途之一。此外，只要科技不断发展，人工智慧在精准医疗中的使用可能会成长。即时监测、穿戴式科技和电子健康记录整合将共同为人工智慧演算法提供持续的资料流进行评估，从而能够及时修改治疗计划和进行干预。

精准医疗市场中的人工智慧 - 关键见解

根据我们的研究分析师分享的分析，预计全球市场在预测期内（2024-2032）每年将以 20.10% 左右的复合年增长率成长

基于技术细分，预计深度学习类别将在 2023 年呈现最大市场份额

依组件细分，2023年软体类别为主导类型

按地区划分，北美是 2023 年的主要收入来源

精准医疗市场中的人工智慧-細項分析：

全球精准医疗市场人工智慧根据技术、组件、治疗应用和区域进行细分。

市场依技术分为两类：机器学习、查询方法、深度学习、情境感知处理和自然语言处理。深度学习类别主导市场。此细分市场的成长可归因于其高处理能力、资料中心功能的进步以及自动化流程的能力。现代深度学习演算法现在可以跨时间和模式对来自个体的多个资料集进行整合和建模，从而提高预测准确性和针对特定患者的治疗建议。

根据治疗应用，市场分为以下几类：肿瘤学、神经学、心臟病学、呼吸系统和其他。肿瘤学类别在市场中占据主导地位，并可能在预测期内保持其主导地位。肿瘤学领域的人工智慧（AI）预计将透过促进更快速、更准确的癌症诊断来推动该行业在整个预测期内的成长，从而提高患者收入。预计推动肿瘤学产业发展的主要因素是癌症发生率的上升和医疗基础设施的扩大。此外，预计医院设施中的医生和护士等医务人员将严重短缺，这将增加对技术的需求。

精准医疗市场中的人工智慧-地理洞察

从地理来看，该市场广泛分布于北美、拉丁美洲、欧洲、亚太、中东和非洲等地区。这些区域根据开展业务的国家进一步划分。

在预测期内，预计北美将在全球精准医疗人工智慧市场中占据最大份额。雅培（Abbott）、达能（Danone）、Targeted Medical Pharma, Inc.、雀巢（Nestle）和美赞臣公司（Mead Johnson & Company, LLC）等主要参与者的策略存在对市场的成长有贡献。例如，生物模拟先驱 Certara, Inc. 于 2022 年 7 月宣布，将与纪念斯隆凯特琳癌症中心合作两年，开发新的生物模拟软体。透过这种合作关係，企业可以创建一个用于 CAR T 细胞治疗的生物模拟平台。此外，经过特殊修饰的免疫系统T细胞被用于CAR T细胞疗法（也称为免疫疗法），以治疗特定形式的血癌。

此外，由于人们支付医疗保健的能力不断增强以及技术发展的步伐，预计在欧洲，精准医疗市场中的人工智慧将以全球最快的速度扩张。政府不断采取的措施正在推动区域市场的扩张。为了开发创新的癌症检测、诊断和治疗解决方案（尤其是基于人工智慧的解决方案），创新者和研究人员需要帮助将现实世界的肿瘤学资料转化为所需的品质和规模。这是欧洲癌症成像计划的目标。

精准医疗市场中的人工智慧-竞争格局：

英特尔公司、Insilico Medicines、NVIDIA 公司、微软公司和阿斯特捷利康公司等众多主要参与者都生产人工智慧产品或推出人工智慧在精准医疗领域的新颖应用。这些公司製定了多种策略来增加其市场份额。市场的这些发展包括新产品的推出、合约、大型投资、併购以及与其他组织的合作。在不断上升的市场环境中发展和生存的一项有吸引力的策略是提供具有成本效益的产品。此外，在预估期间，由于监管机构批准的产品，市场预计将达到显着水准。

最近的发展：

2024 年 1 月：西门子医疗与印度科学研究所 (IISc) 在班加罗尔成立了西门子医疗计算数据科学 (CDS) 合作实验室。这是一个结合人工智慧（AI）和精准医疗的突破性计画。 CDS 合作实验室致力于开发开源人工智慧工具，专注于神经影像领域的进展。这些将成为自动准确描述神经影像资料中异常发现的关键工具。

2023 年 3 月：为了帮助製药公司、生技公司和其他利害关係人加快药物发现和精准医疗，Google Cloud 推出了两种新的基于人工智慧 (Al) 的生命科学解决方案。研究团队可以藉助标靶和先导物来辨识套件更准确地辨识胺基酸的作用。预计这种方法将改善其服务组合併有助于巩固其在市场中的地位。

目录

第一章：精准医疗市场中的人工智慧概述

  • 研究范围
  • 市场预估年份

第 2 章：执行摘要

  • 市场片段
    • 精准医疗市场中的人工智慧技术片段
    • 精准医疗市场中的人工智慧按组件片段
    • 人工智慧在精准医疗市场片段（依治疗应用）
    • 人工智慧在精准医疗市场片段（按国家/地区）
    • 人工智慧在精准医疗市场片段（按地区）
  • 竞争洞察

第 3 章：精准医疗中的人工智慧主要市场趋势

  • 精准医疗市场驱动因素中的人工智慧
    • 市场驱动因素的影响分析
  • 人工智慧对精准医疗市场的限制
    • 市场限制影响分析
  • 人工智慧在精准医疗市场机会
  • 人工智慧在精准医疗市场的未来趋势

第 4 章：精准医疗产业中的人工智慧研究

  • PEST分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第 5 章：精准医疗市场中的人工智慧：COVID-19 影响分析

  • COVID-19 之前的影响分析
  • COVID-19 后影响分析
    • 表现最佳的市场区隔
    • 边际增长部分
    • 最鬆散的部分
    • 边际损失部分

第 6 章：精准医疗市场格局中的人工智慧

  • 人工智慧在精准医疗市场占有率分析，2023 年
  • 按主要製造商分類的故障数据
    • 既定玩家分析
    • 新兴玩家分析

第 7 章：精准医疗市场中的人工智慧 - 按技术分类

  • 概述
    • 按技术分類的细分市场份额分析
    • 机器学习
    • 查询方式
    • 深度学习
    • 情境感知处理
    • 自然语言处理

第 8 章：精准医疗市场中的人工智慧 - 按组成部分

  • 概述
    • 按组成部分分類的细分市场占有率分析
    • 硬体
    • 软体
    • 服务

第 9 章：精准医疗市场中的人工智慧 - 按治疗应用

  • 概述
    • 按治疗应用分類的细分市场份额分析
    • 肿瘤学
    • 神经病学
    • 心臟病学
    • 呼吸系统
    • 其他的

第 10 章：精准医疗市场中的人工智慧 - 按地理位置

  • 介绍
    • 按地理位置分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 精准医疗中的人工智慧北美主要製造商
    • 北美市场规模和预测（按国家）
    • 北美市场规模和预测（按技术）
    • 北美市场规模和预测（按组成部分）
    • 北美市场规模与预测（按治疗应用）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 精准医疗中的人工智慧欧洲主要製造商
    • 欧洲市场规模和预测（按国家）
    • 欧洲市场规模与预测（按技术）
    • 欧洲市场规模和预测（按组成部分）
    • 欧洲市场规模与预测（按治疗应用）
    • 德国
    • 义大利
    • 英国
    • 法国
    • 俄罗斯
    • 荷兰
    • 瑞典
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 精准医疗中的人工智慧亚太区主要製造商
    • 亚太地区市场规模与预测（按国家）
    • 亚太地区市场规模与预测（按技术）
    • 亚太地区市场规模和预测（按组成部分）
    • 亚太地区市场规模与预测（按治疗应用）
    • 印度
    • 中国
    • 日本
    • 韩国
    • 澳洲
    • 泰国
    • 印尼
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲
    • 概述
    • 精准医疗中的人工智慧主要製造商
    • 拉丁美洲市场规模与预测（按国家）
    • 拉丁美洲市场规模与预测（按技术）
    • 拉丁美洲市场规模和预测（按组成部分）
    • 拉丁美洲市场规模与预测（按治疗应用）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲
    • 概述
    • 精准医疗中的人工智慧中东和非洲主要製造商
    • 中东和非洲市场规模及预测（按国家）
    • 中东和非洲市场规模及预测（按技术）
    • 中东和非洲市场规模及预测（按组成部分）
    • 中东和非洲市场规模及预测（按治疗应用）
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 的其余部分

第11章：关键供应商分析-精准医疗产业人工智慧

  • 竞争仪表板
  • 公司简介
    • Intel Corporation
    • Insilico Medicines
    • NVIDIA Corporation
    • Zephyr AI
    • Atomwise Inc
    • Microsoft Corporation
    • AtraZeneca
    • Enlitic Inc.
    • Modernizing machine Inc.
    • BioXcel Therapeutics, Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法论
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
Product Code: ANV2902

REPORT HIGHLIGHT

Artificial Intelligence in Precision Medicine Market size was valued at USD 1,854.2 Million in 2023, expanding at a CAGR of 20.10% from 2024 to 2032.

Precision medicine has never been the same since artificial intelligence (AI) has made it possible to evaluate enormous volumes of biological, clinical, and lifestyle data to customize medicines and treatments for specific patients. With the use of AI algorithms, precision medicine practitioners can now sift and decipher intricate genetic and molecular data, find patterns, and create individualized predictions regarding a patient's prognosis, likelihood of developing a disease, and reaction to various therapies. Clinical professionals can benefit from AI-powered systems that can forecast probable side effects or problems, make more accurate diagnoses, and choose targeted therapies by integrating data from several sources, including wearables, electronic health records, and genetic sequencing.

Artificial Intelligence in Precision Medicine Market- Market Dynamics

Growing Chronic Diseases Prevalence to Propel Market Growth

Chronic diseases, also known as non-communicable diseases (NCDs), are a broad category of medical ailments that include respiratory disorders, diabetes, cancer, and cardiovascular diseases. Their protracted length, gradual advancement, and constant need for medical care and supervision define them. The World Health Organization (WHO) reports that nearly 71% of deaths worldwide are attributable to chronic diseases, with low- and middle-income nations accounting for an astounding 85% of these deaths. Chronic illnesses have a significant negative socioeconomic impact on people's quality of life, as well as on healthcare systems, workforce productivity, and individual and family quality of life. The healthcare sector has seen a significant transformation due to artificial intelligence, particularly in the areas of machine learning and deep learning. Al is capable of producing predictive models, processing and analyzing enormous datasets, and identifying intricate patterns. With Al's application to precision medicine, more precise diagnoses and individualized therapeutic interventions can be achieved by exploring the complex interactions among genetic composition, illness susceptibility, and treatment outcomes. Genomic research represents one of the major uses of Al in precision medicine. Additionally, the use of Al in precision medicine will probably grow as long as technology keeps developing. Real-time monitoring, wearable technology, and electronic health record integration will all work together to offer Al algorithms a constant stream of data to evaluate, allowing for prompt treatment plan modifications and interventions.

Artificial Intelligence in Precision Medicine Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 20.10% over the forecast period (2024-2032)

Based on technology segmentation, the deep learning category was predicted to show maximum market share in the year 2023

Based on component segmentation, the software category was the leading type in 2023

On the basis of region, North America was the leading revenue generator in 2023

Artificial Intelligence in Precision Medicine Market- Segmentation Analysis:

The Global Artificial Intelligence in Precision Medicine Market is segmented on the basis of Technology, Component, Therapeutic Application, and Region.

The market is divided into two categories based on technology: Machine Learning, Querying Method, Deep Learning, Context-Aware Processing, and Natural Language Processing. The deep learning category dominates the market. The segment's growth can be attributed to its high processing power, advancements in data center capabilities, and its capacity for automated processes. Modern deep learning algorithms can now integrate and model several data sets from an individual across time and modalities, improving prediction accuracy and therapy recommendations for specific patients.

The market is divided into the following categories based on therapeutic application: Oncology, Neurology, Cardiology, Respiratory, and Others. The oncology category dominates the market and is likely to maintain its dominance during the forecast period. Artificial intelligence (AI) in oncology is expected to drive the industry's growth throughout the projected period by facilitating more rapid and accurate cancer diagnosis, which in turn improves patient income. The major factors that are anticipated to drive the oncology industry are the rising incidence of cancer and the expanding medical infrastructure. Additionally, it is anticipated that there will be a serious scarcity of medical staff-such as doctors and nurses-in hospital facilities, which will raise demand for technology.

Artificial Intelligence in Precision Medicine Market- Geographical Insights

Geographically, this market is widespread in the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Over the course of the forecast period, North America is anticipated to hold the greatest share of the global market for artificial intelligence in precision medicine. The strategic presence of major players, including Abbott, Danone, Targeted Medical Pharma, Inc., Nestle, and Mead Johnson & Company, LLC, is credited with the market's growth. For instance, the biosimulation pioneer Certara, Inc. announced in July 2022 that it would be working with Memorial Sloan Kettering Cancer Center for two years to develop new biosimulation software. Through this partnership, businesses may create a biosimulation platform for the treatment of CAR T cells. Moreover, immune system T-cells that have undergone a special modification are used in CAR T-cell therapy, also referred to as immunotherapy, to treat specific forms of blood cancer.

In addition, the artificial intelligence in precision medicine market is anticipated to expand at the fastest rate in the world during the projected period in Europe because of the population's increasing ability to pay for healthcare and the pace at which technology is developing. The growing government initiatives are fueling the expansion of the regional market. In order to develop innovative cancer detection, diagnosis, and treatment solutions-especially those based on artificial intelligence-innovators and researchers need assistance translating real-world oncology data on the quality and scale required. This is the goal of the European Cancer Imaging Initiative.

Artificial Intelligence in Precision Medicine Market- Competitive Landscape:

Numerous key players, including Intel Corporation, Insilico Medicines, NVIDIA Corporation, Microsoft Corporation, and AstraZeneca, among others, produce goods or introduce novel applications of AI in precision medicine. These companies have developed several strategies to increase their market share. These developments in the market include the introduction of new products, contracts, large investments, mergers and acquisitions, and partnerships with other organizations. One attractive strategy for growing and surviving in the rising market climate is to offer cost-effective products. Furthermore, during the projected period, the market is expected to reach a notable extent due to the product approvals granted by regulatory authorities.

Recent Developments:

January 2024: The Siemens Healthineers-Computational Data Sciences (CDS) Collaborative Laboratory was launched by Siemens Healthineers and the Indian Institute of Science (IISc) in Bangalore. This is a ground-breaking project that combines artificial intelligence (AI) and precision medicine. Committed to developing open-source AI tools, the CDS collaborative laboratory is focused on progressing in the area of neuroimaging. These will be key instruments in automating the accurate delineation of abnormal findings in neuroimaging data.

March 2023: In order to help pharmaceutical businesses, biotech companies, and other stakeholders expedite drug discovery and precision medicine, Google Cloud has introduced two new artificial intelligence (Al)-based life sciences solutions. Research teams can more accurately identify the role of amino acids with the aid of the target & lead identification suite. It is anticipated that this approach will improve its service portfolio and help to solidify its position in the market.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

Intel Corporation

Insilico Medicines

NVIDIA Corporation

Zephyr AI

Atomwise Inc

Microsoft Corporation

AtraZeneca

Enlitic Inc.

Modernizing machine Inc.

BioXcel Therapeutics, Inc.

Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY TECHNOLOGY- MARKET ANALYSIS, 2019 - 2032

  • Machine Learning
  • Querying Method
  • Deep Learning
  • Context-Aware Processing
  • Natural Language Processing

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY COMPONENT- MARKET ANALYSIS, 2019 - 2032

  • Hardware
  • Software
  • Service

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY THERAPEUTIC APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Oncology
  • Neurology
  • Cardiology
  • Respiratory
  • Others

GLOBAL ARTIFICIAL INTELLIGENCE IN PRECISION MEDICINE MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Artificial Intelligence in Precision Medicine Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Artificial Intelligence in Precision Medicine Market Snippet by Technology
    • 2.1.2. Artificial Intelligence in Precision Medicine Market Snippet by Component
    • 2.1.3. Artificial Intelligence in Precision Medicine Market Snippet by Therapeutic Application
    • 2.1.4. Artificial Intelligence in Precision Medicine Market Snippet by Country
    • 2.1.5. Artificial Intelligence in Precision Medicine Market Snippet by Region
  • 2.2. Competitive Insights

3. Artificial Intelligence in Precision Medicine Key Market Trends

  • 3.1. Artificial Intelligence in Precision Medicine Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Artificial Intelligence in Precision Medicine Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Artificial Intelligence in Precision Medicine Market Opportunities
  • 3.4. Artificial Intelligence in Precision Medicine Market Future Trends

4. Artificial Intelligence in Precision Medicine Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Artificial Intelligence in Precision Medicine Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Artificial Intelligence in Precision Medicine Market Landscape

  • 6.1. Artificial Intelligence in Precision Medicine Market Share Analysis, 2023
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Artificial Intelligence in Precision Medicine Market - By Technology

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Technology, 2023 & 2032 (%)
    • 7.1.2. Machine Learning
    • 7.1.3. Querying Method
    • 7.1.4. Deep Learning
    • 7.1.5. Context-Aware Processing
    • 7.1.6. Natural Language Processing

8. Artificial Intelligence in Precision Medicine Market - By Component

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Component, 2023 & 2032 (%)
    • 8.1.2. Hardware
    • 8.1.3. Software
    • 8.1.4. Service

9. Artificial Intelligence in Precision Medicine Market - By Therapeutic Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Therapeutic Application, 2023 & 2032 (%)
    • 9.1.2. Oncology
    • 9.1.3. Neurology
    • 9.1.4. Cardiology
    • 9.1.5. Respiratory
    • 9.1.6. Others

10. Artificial Intelligence in Precision Medicine Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2023 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Artificial Intelligence in Precision Medicine Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Artificial Intelligence in Precision Medicine Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Technology, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Component, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Therapeutic Application, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Artificial Intelligence in Precision Medicine Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Intel Corporation
    • 11.2.2. Insilico Medicines
    • 11.2.3. NVIDIA Corporation
    • 11.2.4. Zephyr AI
    • 11.2.5. Atomwise Inc
    • 11.2.6. Microsoft Corporation
    • 11.2.7. AtraZeneca
    • 11.2.8. Enlitic Inc.
    • 11.2.9. Modernizing machine Inc.
    • 11.2.10. BioXcel Therapeutics, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Artificial Intelligence in Precision Medicine Market: Technology Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Technology
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Technology 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Component Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Component
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Component 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Therapeutic Application Snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Therapeutic Application
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Therapeutic Application 2019-2032 (USD Million)
  • TABLE Artificial Intelligence in Precision Medicine Market: Regional snapshot (2023)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Artificial Intelligence in Precision Medicine Market, by Region 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE North America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Europe Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Asia Pacific Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Latin America Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Country, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Technology, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Component, 2019-2032 (USD Million)
  • TABLE Middle East and Africa Artificial Intelligence in Precision Medicine Market, by Therapeutic Application, 2019-2032 (USD Million)